Shaperon

Shaperon EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of Shaperon (378800.KQ) as of Nov 2, 2026 is -56.82 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was -78.52 % — a change of -27.63% (higher).

EBIT/Assets

-56.82 %

YoY

-27.63%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Shaperon is 2025 -56.82 % . Operating Income to Assets Ratio (EBIT/Assets) of Shaperon was 2024 -78.52 % . It decreases by -27.63% higher compared to the previous year.

The Shaperon EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2019
-43.04 KRW
Jan 1, 2020
-21.48 KRW
Jan 1, 2021
-38.73 KRW
Jan 1, 2022
-31.38 KRW
Jan 1, 2023
-52.90 KRW
Jan 1, 2024
-78.52 KRW
Jan 1, 2025
-56.82 KRW
The Shaperon EBIT/Assets history
YEAREBIT/AssetsYoY
-56.82 %-27.63%
-78.52 %+48.44%
-52.90 %+68.57%
-31.38 %-18.98%
-38.73 %+80.34%
-21.48 %-50.10%
-43.04 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shaperon Stock analysis

What does Shaperon do? Shaperon Inc is a biotechnology company based in Seoul, South Korea, operating within the healthcare sector. The company focuses on the development of pharmaceutical products targeting conditions such as atopic dermatitis, septicemia, and Alzheimer's disease. Shaperon Inc. has a workforce of 40 full-time employees. The company completed its initial public offering (IPO) on October 19, 2022, and is listed under the ticker symbol 378800.KQ with ISIN KR7378800007. Its website is http://shaperon.com/. Shaperon Inc. is engaged in research, development, manufacturing, and commercialization of therapeutic solutions for pneumonia, Alzheimer's disease, and atopic conditions, among other medicines. The company's headquarters are located in Seoul, South Korea. Shaperon Inc. operates as a publicly traded entity following its IPO in 2022, with a focus on advancing treatments for complex medical conditions through biotechnology innovation. Shaperon is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shaperon stock

Operating Income to Assets Ratio (EBIT/Assets) of Shaperon is -56.82 % in 2025.

Operating Income to Assets Ratio (EBIT/Assets) of Shaperon changed from -78.52 % to -56.82 %, representing a -27.63% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Shaperon since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Shaperon with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Shaperon

All Key Metrics — Shaperon